Fig. 3: The change in the numbers of myeloablative versus non-myeloablative allogeneic HCT performed in Europe during the years 2000–2020.

Change in the numbers of MAB versus NMA HCT in Europe 2000–2020.
Change in the numbers of MAB versus NMA HCT in Europe 2000–2020.